MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns for affordable early detection.

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types ...

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities ...

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, ...

A team of researchers from UCLA has created a new blood test that may change how doctors detect cancer and other diseases.

Prevalence of androgen receptor ligand-binding domain mutations (AR-LBDm) in circulating tumor DNA (ctDNA) versus tissue biopsies in participants (pts) with metastatic castration-resistant prostate ...

At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.

Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...